SEARCH

SEARCH BY CITATION

References

  • AHARONY, D., SMITH, J.B. & SILVER, M.J. (1982). Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroxyperoxyeicosatetraenoic acid. Biochim. biophys. Acta, 718, 193200.
  • ARDLIE, N.G., PACKHAM, M.A. & MUSTARD, J.F. (1970). Adenosine diphosphate-induced platelet aggregation in suspension of washed rabbit platelets. Br J. Haematol., 19, 716.
  • BILLS, T.K., SMITH, J.B. & SILVER, M.J. (1976). Metabolism of 14C-arachidonic acid by human platelets. Biochim. biophys. Acta, 424, 303314.
  • BLACKWELL, G.J., FLOWER, R.J., NIJKAMP, F.P. & VANE, J.R. (1978). Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br. J. Pharmac., 62, 7989.
  • BORN, G.V.R. & CROSS, M.J. (1963). The aggregation of blood platelets. J. Physiol., 168, 178195.
  • BOULLIN, D.J. & GLENTON, P.A.M. (1978). Characterization of receptors mediating 5-hydroxytryptamine and cathecholamine-induced platelet aggregation, assessed by the actions of α- and β-blockers, butyrophenones, 5-HT antagonists and chlorpromazine. Br. J. Pharmac., 62, 537542.
  • BRODDE, O.E., EYMER, T. & ARROYO, J. (1983). 3H-yohimbine binding to guinea-pig kidney and calf cerebral cortex membranes: comparison with human platelets. Arch. int. Pharmacodyn. Ther., 266, 208220.
  • CARLINI, C.R. & GUIMARÃES, J.A. (1981). Isolation and characterization of a toxic protein from Canavalia ensiformis (jack bean) seeds, distinct from concanavalin A. Toxicol., 19, 667676.
  • CARLINI, C.R., RIBEIRO, J.M.C & GUIMARÃES, J.A. (1982). Structure-activity relationships of canatoxin's effects on platelet aggregation. Ann. Acad. brasil. Ciênc., 54, 762763 (abstract).
  • CARLINI, C.R., GOMES, C.B., GUIMARÃES, J.A., MARKUS, R.P., SATO, H. & TROLIN, G. (1984). Central nervous effect of the convulsant protein canatoxin. Acta Pharmac. Tox., 54, 161164.
  • CAZENAVE, J-P., BENVENISTE, J. & MUSTARD, J.F. (1979). Aggregation of rabbit platelets by platelet-aggregating-factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane active drugs. Lab. Invest., 41, 275285.
  • CERLETTI, C., LIVIO, M., GABRIELLA DONI, M. & DE GAETANO, G. (1983). Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities. Biochim. biophys. Acta., 759, 125127.
  • COSTA, J.L. & MURPHY, D.L. (1975). Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Science, 255, 407408.
  • CROSET, M. & LAGARDE, M. (1983). Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of eicosaenoic acids. Biochem. biophys. Res. Commun., 112, 878883.
  • DUTILH, C.E., HADDEMAN, E. & TEN HOOR, F. (1980). Role of arachidonic lipoxygenase pathway in blood platelet aggregation. Adv. Prost. Thromb. Res., 6, 101105.
  • DUTILH, C.E., HADDEMAN, E., DON, J.A. & TEN HOOR, F. (1981). The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro. Prostaglandin Med, 6, 111126.
  • GORMAN, R.R., BUNTING, S. & MILLER, O.V. (1977). Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins, 13, 377388.
  • GRAF, M. & PLETSCHER, A. (1979). Shape change of blood platelets — a model for cerebral 5-hydroxytryptamine receptors Br. J. Pharmac., 65, 601608.
  • HABERMANN, E. (1978). Tetanus. In Handbook of Clinical Neurology, ed. Vinker, P.J. & Bruyn, G.W. Vol. 33, part I, pp. 491547, New York: North-Holland Publishing Co.
  • HAMBERG, M. (1976). On the formation of thromboxane B2 and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (12ho-20:4) in tissues from the guinea-pig. Biochem. biophys. Acta, 431, 651654.
  • HAMBERG, M. & SAMUELSSON, B. (1974). Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc natn. Acad. Sci. U.S.A., 71, 34003404.
  • HIGGS, G.A., FLOWER, R.F. & VANE, J.R. (1979). A new approach to anti-inflammatory drugs. Biochem. Pharmac., 28, 19591961.
  • HIGGS, G. A. & VANE, J.R. (1983). Inhibition of cyclo-oxygenase and lipoxygenase. Br. Med. Bull., 39, 265270.
  • JENKINS, C.S.P., PACKHAM, M.A., KINLOUGH-RATHBONE, R.L. & MUSTARD, J.F. (1971). Interactions of polylysine with platelets. Blood, 37, 395412.
  • KATTLOVE, H.E. & GOMEZ, M.H. (1975). Studies on the mechanism of ristocetin-induced platelet aggregation. Blood, 45, 9196.
  • KINLOUGH-RATHBONE, R.L., CHALIL, A., PACKHAM, M.A., REIMERS, H-J. & MUSTARD, J.F. (1975). Effects of ionophore A 23,187 on thrombin-degranulated washed rabbit platelets. Thromb. Res., 7, 435449.
  • KINLOUGH-RATHBONE, R.L., MUSTARD, J.F., PERRY, D.W., DEJANA, E., CAZENAVE, J.P., PACKHAM, M.A. & HARFENIST, E.J. (1983). Factors influencing the deaggregation of human and rabbit platelets. Thromb. Haemost., 49, 162167.
  • KIRBY, E.P. & MILLS, D.C.B. (1975). The interactions of bovine factor VIII with human platelets. J. Clin. Invest., 56, 491502.
  • LAPETINA, E.G., CHANDRABOSE, K.A. & CUATRECASAS, P. (1978). Ionophore A 23,187- and thrombin-induced platelet aggregation: independence of cyclo-oxygenase products. Proc. natn. Acad. Sci. U.S.A., 75, 818822.
  • MUSTARD, J.F. & PACKHAM, M.A. (1970). Factors influencing platelet function: adhesion, release and aggregation. Pharmac. Rev., 22, 97187.
  • MUSTARD, J.F., PACKHAM, M. A., KINLOUGH-RATHBONE, R.L., PERRY, D.W. & REGOECZI, E. (1978). Fibrinogen and ADP-induced platelet aggregation. Blood, 52, 435466.
  • NADER, H.B., DIETRICH, C.P. & GARCEZ, L.L. (1981). A peculiar chondroitin sulfate released from platelets of several mammalian species during self-aggregation induced by ADP and thrombin. In Glycoconjugates, ed. Yamakawa, T., Osawa, T. & Handa, S. Tokyo: Japan Scientific Press pp. 339340.
  • NISHIGAWA, E.E., WILLIAMS, D.J. & CONNELL, C.L. (1983). Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2. Thromb. Res., 30, 289296.
  • NUGTEREN, D.H. (1982). Arachidonic acid-12-lipoxygenase from bovine platelets. In Methods in Enzymology, ed. Lands, W.E.M. & Smith, W.L. Vol. 86, pp. 550551, New York: Academic Press.
  • PLETSCHER, A. & LAUBSCHER, A. (1980). Use and limitations of platelets as models for neurones: amino release and shape change reaction. In Platelets: Cellular Response Mechanisms and Their Biological Significance, ed. Rotman, A., Meyer, F.A., Gilter, C. & Silberberg, A. pp. 267276. New York: John Wiley and Sons.
  • PRADO-FRANCESCHI, J., TAVARES, D.Q., HERTEL, R. & DE ARAUJO, LOBO A. (1981). Effects of convulxin, a toxin from the rattlesnake venom, on platelets and leukocytes of anesthetized rabbits. Toxicol, 19, 661666.
  • SNEDDON, J.M. (1973). Blood platelets as a model for monoamine-containing neurons. In Progress in Neurobiology, ed. Kerkut, G.A. & Phillis, J.W. Vol. 1, part II, pp. 151198, Oxford: Pergamon Press.
  • STORMORKEN, H. (1969). The release reaction of secretion: a general basic phenomenom related to phagocytosis/pinocytosis. Scand. J. Haematol., (suppl.) 9, 324.
  • TAYLOR, G.W. & MORRIS, H.R. (1983). Lipoxygenase pathways. Br. med. Bull., 39, 219222.
  • VARGAFTIG, B.B. & DAO, N. (1972). Selective inhibition by mepacrine of the release of “Rabbit Aorta Contracting Substance” evoked by the administration of bradykinin. J. Pharm. Pharmac., 24, 159161.
  • VARGAFTIG, B.B., CHIGNARD, M. & BENVENISTE, J. (1981). Present concepts on the mechanisms of platelet aggregation. Biochem. Pharmac., 30, 263271.
  • VARGAFTIG, B.B., CHIGNARD, M., LeCOUEDIC, J.P. & BENVENISTE, J. (1980a). One, two, three or more pathways for platelet aggregation. Acta. Med. Scand. (suppl.), 642, 2329.
  • VARGAFTIG, B.B., JOSEPH, D., WAL, F., MARLAS, G., CHIGNARD, M. & CHEVANCE, L.G. (1983). Convulxin-induced activation of intact and thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen. Eur. J. Pharmac., 92, 5768.
  • VARGAFTIG, B.B., PRADO-FRANCESCHI, J., CHIGNARD, M., LEFORT, J. & MARLAS, G. (1980b). Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavela. Eur. J. Pharmac., 68, 451464.
  • VARGAFTIG, B.B. & ZIRINIS, P. (1973). Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nature (New Biol.), 244, 144116.
  • WATANABE, T., NARUMIYA, S., SHIMIZU, T. & HAYAISHI, O. (1982). Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet rich-plasma. J. biol. Chem., 257, 1484714853.